Insmed INSM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$163.56M+36.3% | -$328.49M-39.5% | -$370.02M-67.8% | -$321.69M-7.0% | -$256.58M-63.3% | ||
| $2.93M+55.8% | $3.62M+145% | $2.46M+68.5% | $2.48M+73.0% | $1.88M+18.6% | ||
| $45.75M+16.5% | $39.04M+47.0% | $31.43M+23.0% | $42.98M+84.6% | $39.26M+83.0% | ||
| $1.38M-24.1% | $1.38M-21.3% | $1.34M-9.6% | $1.68M-6.9% | $1.82M-1.6% | ||
| $38.19M+812% | $77.3M+554% | $10.23M+29,117% | $6.14M+52.2% | -$5.36M-81.4% | ||
| $1.89M+84.7% | $11.76M+454% | $13.76M+109% | $4.98M-35.8% | $1.02M+70.7% | ||
| -$33.88M+44.9% | $90.35M+120% | $45.56M+6,184% | $25.66M-26.9% | -$61.49M-90.1% | ||
| $2.36M+123% | $11.79M+535% | $2.85M— | -$2.35M+84.7% | -$10.17M-2,953% | ||
| -$497K+77.1% | -$914K+80.0% | -$1.1M-76.8% | -$815K-34.9% | -$2.17M+64.7% | ||
| $5.11M+1.8% | $5.33M+5.3% | $5.13M-2.6% | $5.19M+6.1% | $5.02M+4.2% | ||
| $2.08M+64.8% | $1.94M+53.4% | $1.54M+21.8% | $1.26M0.0% | $1.26M0.0% | ||
| -$46.96M-357% | $70.04M— | $104.65M+613% | $59M-43.1% | $18.3M+254% | ||
| -$222.74M+15.0% | -$247.6M-26.3% | -$219.76M-21.5% | -$205.57M-67.2% | -$262.09M-42.4% | ||
| $3.48M-65.4% | $16.59M+145% | $2.42M-34.5% | $3.48M-48.6% | $10.07M+115% | ||
| $284M-60.6% | $436M-39.1% | $425M— | $508M— | $721M+140% | ||
| $265.52M+230% | —— | -$762.23M+24.0% | $227.84M— | $80.41M-72.8% | ||
| $30.31M+2.1% | —— | —— | $793.83M+11.9% | $29.7M+633% | ||
| $799K+13.2% | $776K+13.1% | $747K+13.5% | $732K+13.5% | $706K+13.7% | ||
| $29.51M+1.8% | $33.86M-78.7% | $33.41M-91.6% | $857.81M+9.8% | $29M+860% | ||
| -$553K-162% | $7K+100% | —— | $1.01M+246% | $895K+194% | ||
| $71.74M+147% | —— | -$949.56M-20.9% | $881.08M+35.3% | -$151.78M-234% | ||
| $13.12M0.0% | $13.51M-11.4% | $15.45M+79.0% | $13.27M+56.4% | $13.12M+59.8% | ||
| $2.94M+35.1% | $111K-55.2% | $1.18M+70.8% | $677K+91.2% | $2.18M+80.1% | ||
| $1.38M-24.1% | $1.38M-21.3% | $1.34M-9.6% | $1.68M-6.9% | $1.82M-1.6% | ||
| $2.08M+64.8% | $1.94M+53.4% | $1.54M+21.8% | $1.26M0.0% | $1.26M0.0% | ||
| -$46.96M-357% | $70.04M— | $104.65M+613% | $59M-43.1% | $18.3M+254% | ||
| $2.93M+55.8% | $3.62M+145% | $2.46M+68.5% | $2.48M+73.0% | $1.88M+18.6% | ||
| -$12.59M-174% | $26.22M— | $3.73M— | $6.53M— | $16.94M-12.4% | ||
| $567K-17.3% | $6.9M+408% | $1.17M+89.7% | $888K— | $686K-89.5% | ||
| $15M— | —— | —— | —— | $0— | ||
| $799K+13.2% | $776K+13.1% | $747K+13.5% | $732K+13.5% | $706K+13.7% | ||
| $678K0.0% | $678K0.0% | $678K0.0% | $678K0.0% | $678K0.0% | ||
| $2.94M+35.1% | $111K-55.2% | $1.18M+70.8% | $677K+91.2% | $2.18M+80.1% | ||
| -$226.22M+16.9% | -$264.19M-30.3% | -$222.18M-20.4% | -$209.05M-61.1% | -$272.16M-44.2% | ||
| -$226.22M+16.9% | -$264.19M-30.3% | -$222.18M-20.4% | -$209.05M-61.1% | -$272.16M-44.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insmed generate?
- Insmed (INSM) generated -$895.7M in operating cash flow over the trailing twelve months.
- What is Insmed's free cash flow?
- After $26.0M of capital expenditures, Insmed's free cash flow was -$921.6M over the trailing twelve months, down 16.8% year over year.
- Where does Insmed's cash flow data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
